Home › Calculator › CMVLF Dividend Calculator 2026
CMVLF Dividend DRIP Calculator 2026
57.64% YieldHealthcareCellectis S.A. · OTC
Price: $3.47 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When CMVLF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your CMVLF snowball 📈
$10,000 in CMVLF → $5709245199.49M in 10 years · $474,965,681,866,777.60/month
About Cellectis S.A. (CMVLF) — Dividend Analysis 2026
Cellectis S.A. is a clinical-stage biotechnology firm dedicated to advancing immuno-oncology therapies. Their core technology involves engineering T-cells with gene editing to express chimeric antigen receptors (CARs), enabling these modified cells to precisely target and destroy cancer cells. The company's operations are structured into two principal divisions: Therapeutics and Plants. Its robust development pipeline includes several crucial product candidates. Notable among these is UCART19, an allogeneic T-cell treatment designed for CD19-expressing blood cancers like acute lymphoblastic leukemia. They are also progressing ALLO-501 and ALLO-501A, aimed at tackling relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma. Further candidates encompass ALLO-316 for renal cell carcinoma, UCART123 for acute myeloid leukemia, and UCART22 for B-cell acute lymphoblastic leukemia. Additionally, the company is advancing UCARTCS1 and ALLO-715 in its efforts against multiple myeloma. Cellectis has forged significant strategic partnerships with organizations such as Allogene Therapeutics, Inc., Les Laboratoires Servier, The University of Texas M.D. Anderson Cancer Center, and Iovance Biotherapeutics. Furthermore, it maintains a strategic research and development collaboration with Cytovia Therapeutics, Inc. The company was established in 1999 and its headquarters are located in Paris, France.
Compare CMVLF with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full CMVLF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open CMVLF position with:
🌍 CMVLF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold CMVLF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 57.64% | 54.84% | $5,764 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 48.99% | 46.19% | $4,899 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 46.11% | 43.31% | $4,611 / yr |
| 🇬🇧 UK ISA | 0% | 57.64% | 54.84% | $5,764 / yr |
| 🇬🇧 UK Taxable | 8.75% | 52.60% | 49.80% | $5,260 / yr |
| 🇨🇦 TFSA | 0% | 57.64% | 54.84% | $5,764 / yr |
| 🇨🇦 CA Taxable | 25% | 43.23% | 40.43% | $4,323 / yr |
| 🇦🇺 Super (pension) | 15% | 48.99% | 46.19% | $4,899 / yr |
| 🇦🇺 AU Taxable | 30% | 40.35% | 37.55% | $4,035 / yr |
| 🇩🇪 DE Taxable | 26.375% | 42.44% | 39.64% | $4,244 / yr |
| 🇫🇷 FR Taxable | 30% | 40.35% | 37.55% | $4,035 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 CMVLF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 CMVLF Dividend Payment Schedule
CMVLF pays quarterly — 4 times per year. Next ex-div: TBD.
📊 CMVLF vs Healthcare Benchmarks
How CMVLF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for CMVLF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ CMVLF Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the CMVLF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Cellectis S.A. (CMVLF) is currently trading at $3.47, 88% below its 52-week high. The current dividend yield is 57.64% based on an annual payout of $2.00 per share.
CMVLF (Cellectis S.A.) — 57.64% Dividend Yield Analysis
Cellectis S.A. (CMVLF) is a healthcare stock currently trading at $3.47 with a dividend yield of 57.64%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (57.64%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.